CD19 and leukemia: To test whether the improved anti-tumor activity of the REP T cells in vitro correlated with their in vivo activity in a Nalm6 leukemia mouse model, the leukemia-bearing mice were treated with multiple injections of T cells electroporated with either the CD19-BBZ CAR RNA or Blina-RNA.